Autoantibodies against aminoacyl-tRNA synthetase: novel diagnostic marker for type 1 diabetes mellitus.

Park, Sang Gyu; Park, Ho Seon; Jeong, In-Kyong; Cho, Young Min; Lee, Hong Kyu; Kang, Young-Sun; Kim, Sunghoon; Park, Kyong Soo
Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals
2010Jun ; 15 ( 4 ) :358-66.
ÀúÀÚ »ó¼¼Á¤º¸
Park, Sang Gyu -
Park, Ho Seon -
Jeong, In-Kyong -
Cho, Young Min -
Lee, Hong Kyu -
Kang, Young-Sun -
Kim, Sunghoon -
Park, Kyong Soo -
ABSTRACT
OBJECTIVES: To investigate whether or not antiaminoacyl-tRNA synthetase (aaRS) autoantibodies could be detected in patients with type 1 diabetes mellitus (DM) and be used as a diagnostic marker for type 1 DM, autoantibodies against aaRSs were measured in the plasma of normal subjects, patients with type 1 DM and patients with type 2 DM.

METHODS: An enzyme-linked immunosorbent assay was performed to detect anti-aaRS autoantibodies in the plasma of normal subjects, and patients with type 1 DM, and patients with type 2 DM.

RESULTS: From the 65 (normal), 58 (type 1 DM) and 57 (type 2 DM) subjects, anti-aaRS autoantibodies were found in 37.9% of patients with type 1 DM compared with 1.54% of the non-diabetic controls, and 5.26% of the patients with type 2 DM (p <0.0001). In addition, anti-aaRS autoantibodies were identified in 30% of patients with type 1 DM without classical type 1 DM autoantibodies. CONCLUSION: Anti-aaRS autoantibodies were identified in 37.9% of patients with type 1 DM. The results of this study demonstrate for the first time that autoantibodies against aaRSs are specifically associated with type 1 DM.
Pancreas, autoantibody, antisynthetase syndrome, autoimmune disease, ELISA
MESH
Adult, Amino Acyl-tRNA Synthetases/*immunology, Autoantibodies/analysis/*blood, Biomarkers/analysis/blood, Diabetes Mellitus, Type 1/*diagnosis/immunology, Female, Glutamate Decarboxylase/immunology, Humans, Male, Middle Aged, Pancreas/immunology, Receptor-Like Protein Tyrosine Phosphatases, Class 8/immunology
¸µÅ©

ÁÖÁ¦ÄÚµå
ÁÖÁ¦¸í(Target field)
¿¬±¸´ë»ó(Population)
¿¬±¸Âü¿©(Sample size)
´ë»ó¼ºº°(Gender)
Áúº´Æ¯¼º(Condition Category)
¿¬±¸È¯°æ(Setting)
¿¬±¸¼³°è(Study Design)
¿¬±¸±â°£(Period)
ÁßÀç¹æ¹ý(Intervention Type)
ÁßÀç¸íĪ(Intervention Name)
Å°¿öµå(Keyword)
À¯È¿¼º°á°ú(Recomendation)
Á¦ 1 Çü ´ç´¢º´¿¡ ´ëÇÑ »õ·Î¿î Áø´Ü ¸¶Ä¿¿¬±¸·Î Ç× ¾Æ¹Ì³ë ¾Æ½Ç -tRNA ÇÕ¼º È¿¼Ò (aaRS)¿¡ ´ëÇÑ ÀÚ°¡ Ç×ü´Â Á¦ 1 Çü ´ç´¢º´°ú °ü·ÃÀÌ ÀÖÀ½À» º¸°í: Autoantibodies against antiaminoacyl-tRNA synthetase (aaRS) are specifically associated with type 1 DM.
¿¬±¸ºñÁö¿ø(Fund Source)
±Ù°Å¼öÁØÆò°¡(Evidence Hierarchy)
ÃâÆdz⵵(Year)
Âü¿©ÀúÀÚ¼ö(Authors)
´ëÇ¥ÀúÀÚ
DOI
10.3109/13547501003777823
KCDÄÚµå
ICD 03
°Ç°­º¸ÇèÄÚµå